BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 6230121)

  • 1. Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
    Ludwig H; Linkesch W; Gisslinger H; Fritz E; Sinzinger H; Radaszkiewicz T; Chott A; Flener R; Micksche M
    Cancer Immunol Immunother; 1987; 25(3):266-73. PubMed ID: 3677127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A megakaryocyte analysis of the bone marrow in patients with myelodysplastic syndrome, myeloproliferative disorder and allied disorders.
    Ohshima K; Kikuchi M; Takeshita M
    J Pathol; 1995 Oct; 177(2):181-9. PubMed ID: 7490685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia.
    Mukaida N; Tanabe Y; Baba T
    Mol Biomed; 2021 Mar; 2(1):7. PubMed ID: 35006395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell analysis of ploidy and the transcriptome reveals functional and spatial divergency in murine megakaryopoiesis.
    Sun S; Jin C; Si J; Lei Y; Chen K; Cui Y; Liu Z; Liu J; Zhao M; Zhang X; Tang F; Rondina MT; Li Y; Wang QF
    Blood; 2021 Oct; 138(14):1211-1224. PubMed ID: 34115843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryocytes as immune cells.
    Cunin P; Nigrovic PA
    J Leukoc Biol; 2019 Jun; 105(6):1111-1121. PubMed ID: 30645026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes.
    Levene RB; Lamaziere JM; Broxmeyer HE; Lu L; Rabellino EM
    J Exp Med; 1985 Mar; 161(3):457-74. PubMed ID: 3973535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of polyploidy in megakaryocytes and other cells in health and tumor disease.
    Winkelmann M; Pfitzer P; Schneider W
    Klin Wochenschr; 1987 Dec; 65(23):1115-31. PubMed ID: 3323647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical study on the maturation of human megakaryocytes using microfluorometry.
    Maruo N; Kobayashi Y; Horiuchi H; Kondo M; Fujita S
    Histochemistry; 1992; 97(2):141-5. PubMed ID: 1559845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ; Thiele J
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human megakaryocytes. III. Characterization in myeloproliferative disorders.
    Rabellino EM; Levene RB; Nachman RL; Leung LL
    Blood; 1984 Mar; 63(3):615-22. PubMed ID: 6230121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes.
    Rabellino EM; Levene RB; Leung LL; Nachman RL
    J Exp Med; 1981 Jul; 154(1):88-100. PubMed ID: 6788894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
    Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
    Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathologic study on megakaryocytes in chronic myeloproliferative disorders].
    Lin N; Liang P
    Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):113-5. PubMed ID: 1914016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.